Webcvs caremark corporation (nyse:cvs) recently completed the $2. 1 billion acquisition of drug infusion services provider coram llc.

Webdrugstore chain cvs caremark corp.

Completed its $2. 1 billion acquisition of the drug infusion business coram llc, and it expects the deal to start helping earnings.

Recommended for you

Webin an effort to develop its specialty pharmacy business, cvs caremark (nyse:cvs) unveiled a $2. 1 billion deal on wednesday to acquire the specialty infusion.

You may also like